对大多数大型制药企业而言，下定决心走多元化经营的道路实在是一种应对目前困境的正确的选择。
That is especially true if you are desperate to diversify, as most big pharmaceutical companies are these days.
没错，大多数的管理者会愿意体验那种不常有的胜利，好让他们觉得日常的工作是值得的，但是对企业而言，重要的事情往往是那些“细枝末节”。
Sure, most managersget to experience the occasional big success that makes the day-to-day routineworth enduring, but it’s often the little things that count when it comes tobusiness.
应用推荐